Neural apoptosis-regulated convertase 1
| Catalog# | Product Description | Host Species | Nature | Cross reactivity | Quantity | Volume | Price |
|---|---|---|---|---|---|---|---|
| NARC-101AP | NARC antibodies | Rabbit | AP | r, m, h | 100.0 ug | 150-500 ul |
$245.00
|
| FITC-NARC | FITC-conjugated antibodies | Rabbit | FITC-AP | r, m, h | 100.0 ug | 150-500 ul |
$350.00
|
| P-NARC | Antigenic blocking peptide | n/a | Synthetic peptide | n/a | 250.0 ug | 100 ul |
$125.00
|
| PC-NARC | WB positive control for NARC | n/a | Protein in ready-to-use buffer | n/a | 0.0 ug | 150 ul |
$185.00
|
The Neural apoptosis-regualted convertase 1 (NARC1) is encoded by gene proprotein convertase subtilsin kexin Type 9 (PCSK9) and is known to play a role in cholesterol homeostasis and is implicated in the differentiation of cortical neurons.. Proprotein convertase subtilisin/kexin type 9 (PCSK9) causes a third form of autosomal dominant hypercholesterolemia. NARC1 along with other known apoptotic mediators (caspase-3 and death receptor 6) are co-regulated and their mRNA levels are induced in cerebellar granule neurons after apoptotic injury. The NARC1 have significant pro-apoptotic effects that are partially reversed by polycaspase inhibitor BAF (1). Loss of function mutations (c.43_44insCTG) in the PCSK9 gene caused an in-frame insertion in African American and Caucasian population is associated with the etiology of familial hypobetalipoproteinemia (FHBL). This inframe mutation in NARC1 gene is involved in lowering cholesterol in the general population (2). This suggests that the variants of PCSK9 found in FH influence the secretion of apoB-containing lipoproteins, providing an explanation for the marked increase in circulating LDL in heterozygous carriers.
NARC1 is a 692 amino acid protein, expressed in neuro-epithelioma, colon carcinoma, hepatic and pancreatic cell lines and in Schwan cells. The NARC1 mRNA is abundantly expressed in yolk sac and fetal liver, but the highest protein levels are found in differentiated FOA-1 cells which also exhibit highest levels of LDL receptor levels. The cellular levels of NARC1 in ER and intermediate vesicular compartment are reduced by cholesterol and 25-Hydroxy-cholesterol and up-regulated in tandem with HMG-CoA reductase, synthase and LDLR in the presence of steroids (3). The NARC1 is processed in the ER and secreted in the plasma. The NARC 1 gene encodes a novel proteinase K family proteinase. The domain structure of rat Narc 1 resembles that of the subtilisin-like proprotein convertases (SPCs), except that rNarc 1 lacks the canonical P-domain of SPCs, retaining only the RGD motif as part of what might be a cryptically functioning P-domain. NARC1 undergoes autocatalytic intramolecular processing at the site LVFAQ/, resulting in the cleavage of its pro-segment and the generation of an active proteinase with a broad alkaline pH optimum and no apparent calcium requirement for activity (4).
The NARC1-selective antibodies were made in rabbits using synthetic peptide form the amino terminal end of the protein. Anti-NARC1 antibodies label a 84-86 kDa protein in PC-NARC1 samples. Anti-NARC1-selective antibody is available in affinity-purified form isolated by immobilized affinity chromatography for confocal, Western blotting and immunocytochemical analyses. FabGennix Inc. will also conjugate antibodies with fluorescent probes upon request at extra charge. FabGennix Inc. also provides antibodies against other protein kinases, proteinases and convertases, for a complete listing please visit www.FabGennix.com. FabGennix, Inc., will also provide Western blot positive controls for most of these antibodies in ready-to-use buffer for easy identification of respective proteins. Limited quantities of antigens are also available. Please enquire for their availability before ordering.
For research use only, not for diagnostic or therapeutic use.
Data Sheets
MSDS
General Information
Citations
Search FabGennix Product Citation Data Base
Search